Raphael B. Stricker

4.0k total citations
110 papers, 2.3k citations indexed

About

Raphael B. Stricker is a scholar working on Infectious Diseases, Parasitology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Raphael B. Stricker has authored 110 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Infectious Diseases, 40 papers in Parasitology and 25 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Raphael B. Stricker's work include Vector-borne infectious diseases (37 papers), Viral Infections and Vectors (24 papers) and HIV Research and Treatment (19 papers). Raphael B. Stricker is often cited by papers focused on Vector-borne infectious diseases (37 papers), Viral Infections and Vectors (24 papers) and HIV Research and Treatment (19 papers). Raphael B. Stricker collaborates with scholars based in United States, Canada and Greece. Raphael B. Stricker's co-authors include Lorraine Johnson, Edward E. Winger, W J Morrow, Marianne J. Middelveen, Jay A. Levy, Marc A. Shuman, D Kiprov, Thomas M. McHugh, Carolyn B. Coulam and David A. Clark and has published in prestigious journals such as Nature, JAMA and Journal of Clinical Investigation.

In The Last Decade

Raphael B. Stricker

105 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raphael B. Stricker United States 27 803 712 557 440 359 110 2.3k
Timothy G. Berger United States 40 827 1.0× 673 0.9× 335 0.6× 301 0.7× 397 1.1× 128 4.5k
Luiza Guilherme Brazil 35 902 1.1× 200 0.3× 713 1.3× 115 0.3× 2.0k 5.7× 80 3.3k
Sheila L. Arvikar United States 19 503 0.6× 431 0.6× 401 0.7× 113 0.3× 137 0.4× 29 1.8k
Harry W. Haverkos United States 28 777 1.0× 155 0.2× 544 1.0× 569 1.3× 216 0.6× 66 2.7k
Carol Harris United States 21 816 1.0× 111 0.2× 377 0.7× 473 1.1× 341 0.9× 41 2.4k
Robert Y. Foos United States 36 489 0.6× 199 0.3× 226 0.4× 408 0.9× 260 0.7× 111 4.6k
Nesli Basgoz United States 32 1.6k 2.0× 88 0.1× 949 1.7× 1.9k 4.3× 177 0.5× 53 4.2k
Adriana Weinberg United States 24 336 0.4× 226 0.3× 370 0.7× 263 0.6× 106 0.3× 38 2.0k
Mark Zuckerman United Kingdom 28 1.2k 1.5× 66 0.1× 245 0.4× 394 0.9× 355 1.0× 98 3.4k
Thais P. Salazar‐Mather United States 25 826 1.0× 132 0.2× 4.9k 8.9× 195 0.4× 189 0.5× 27 6.4k

Countries citing papers authored by Raphael B. Stricker

Since Specialization
Citations

This map shows the geographic impact of Raphael B. Stricker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raphael B. Stricker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raphael B. Stricker more than expected).

Fields of papers citing papers by Raphael B. Stricker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raphael B. Stricker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raphael B. Stricker. The network helps show where Raphael B. Stricker may publish in the future.

Co-authorship network of co-authors of Raphael B. Stricker

This figure shows the co-authorship network connecting the top 25 collaborators of Raphael B. Stricker. A scholar is included among the top collaborators of Raphael B. Stricker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raphael B. Stricker. Raphael B. Stricker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Lorraine, et al.. (2024). Optimizing Exclusion Criteria for Clinical Trials of Persistent Lyme Disease Using Real-World Data. Healthcare. 13(1). 20–20. 1 indexed citations
2.
Middelveen, Marianne J., et al.. (2021). Dermatological and Genital Manifestations of Lyme Disease Including Morgellons Disease. Clinical Cosmetic and Investigational Dermatology. Volume 14. 425–436. 5 indexed citations
3.
Stricker, Raphael B., et al.. (2021). Hydroxychloroquine Pre-Exposure Prophylaxis for COVID-19 in Healthcare Workers from India: A Meta-Analysis. Journal of Infection and Public Health. 14(9). 1161–1163. 5 indexed citations
4.
Middelveen, Marianne J., et al.. (2020). <p>Classification and Staging of Morgellons Disease: Lessons from Syphilis</p>. Clinical Cosmetic and Investigational Dermatology. Volume 13. 145–164. 5 indexed citations
5.
Shah, Jyotsna, Song Liu, М. М. Корда, et al.. (2019). Line Immunoblot Assay for Tick-Borne Relapsing Fever and Findings in Patient Sera from Australia, Ukraine and the USA. Healthcare. 7(4). 121–121. 6 indexed citations
6.
Middelveen, Marianne J., et al.. (2018). Relapsing fever <em>Borrelia</em> in California: a pilot serological study. International Journal of General Medicine. Volume 11. 373–382. 6 indexed citations
7.
Middelveen, Marianne J., et al.. (2018). Detection of tick-borne infection in Morgellons disease patients by serological and molecular techniques. Clinical Cosmetic and Investigational Dermatology. Volume 11. 561–569. 10 indexed citations
8.
Middelveen, Marianne J., et al.. (2018). Clinical evaluation of Morgellons disease in a cohort of North American patients. Dermatology Reports. 10(1). 7660–7660. 9 indexed citations
9.
Stricker, Raphael B. & Marianne J. Middelveen. (2018). Better drugs for Lyme disease: focus on the spirochete. Infection and Drug Resistance. Volume 11. 1437–1439. 3 indexed citations
10.
Stricker, Raphael B., et al.. (2011). Filament formation associated with spirochetal infection: a comparative approach to Morgellons disease. Clinical Cosmetic and Investigational Dermatology. 4. 167–167. 26 indexed citations
11.
Johnson, Lorraine & Raphael B. Stricker. (2010). The Infectious Diseases Society of America Lyme guidelines: a cautionary tale about the development of clinical practice guidelines. Philosophy Ethics and Humanities in Medicine. 5(1). 9–9. 20 indexed citations
12.
Clark, David A., Carolyn B. Coulam, & Raphael B. Stricker. (2006). Is intravenous immunoglobulins (IVIG) efficacious in early pregnancy failure? A critical review and meta-analysis for patients who fail in vitro fertilization and embryo transfer (IVF). Journal of Assisted Reproduction and Genetics. 23(1). 1–13. 72 indexed citations
13.
Stricker, Raphael B., et al.. (2005). Lyme disease: point/counterpoint. Expert Review of Anti-infective Therapy. 3(2). 155–165. 25 indexed citations
14.
Johnson, Lorraine & Raphael B. Stricker. (2004). Treatment of Lyme disease: a medicolegal assessment. Expert Review of Anti-infective Therapy. 2(4). 533–557. 23 indexed citations
15.
Stricker, Raphael B. & Andrew Lautin. (2003). The Lyme Wars: time to listen. Expert Opinion on Investigational Drugs. 12(10). 1609–1614. 5 indexed citations
16.
Stricker, Raphael B., et al.. (2000). Successful treatment of immunologic abortion with low-dose intravenous immunoglobulin. Fertility and Sterility. 73(3). 536–540. 63 indexed citations
17.
Stricker, Raphael B., et al.. (1997). Decrease in viral load associated with topical dinitrochlorobenzene therapy in HIV disease. Research in Virology. 148(5). 343–348. 4 indexed citations
18.
Stricker, Raphael B., et al.. (1995). Improved results of delayed-type hypersensitivity skin testing in HIV-infected patients treated with topical dinitrochlorobenzene. Journal of the American Academy of Dermatology. 33(4). 608–611. 2 indexed citations
19.
Stricker, Raphael B., et al.. (1991). Impact of the HIV epidemic on therapeutic apheresis: Nursing considerations. Journal of Clinical Apheresis. 6(2). 124–126. 2 indexed citations
20.
Stricker, Raphael B., et al.. (1987). Evidence that a 210,000-molecular-weight glycoprotein (GP 210) serves as a platelet Fc receptor.. Journal of Clinical Investigation. 79(6). 1589–1594. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timothy G. Berger Breakdown of academic impact, for papers by Luiza Guilherme Breakdown of academic impact, for papers by Sheila L. Arvikar Breakdown of academic impact, for papers by Harry W. Haverkos Breakdown of academic impact, for papers by Carol Harris Breakdown of academic impact, for papers by Robert Y. Foos Breakdown of academic impact, for papers by Nesli Basgoz Breakdown of academic impact, for papers by Adriana Weinberg Breakdown of academic impact, for papers by Mark Zuckerman Breakdown of academic impact, for papers by Thais P. Salazar‐Mather
Rankless by CCL
2026